Searle & Co’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-14,500
| Closed | -$86K | – | 135 |
|
|
2017
Q4 | $86K | Hold |
14,500
| – | – | 0.05% | 128 |
|
|
2017
Q3 | $107K | Sell |
14,500
-36,500
| -72% | -$269K | 0.07% | 124 |
|
|
2017
Q2 | $346K | Hold |
51,000
| – | – | 0.24% | 97 |
|
|
2017
Q1 | $481K | Buy |
+51,000
| New | +$481K | 0.34% | 83 |
|
|
2016
Q4 | – | Sell |
-105,000
| Closed | -$726K | – | 117 |
|
|
2016
Q3 | $726K | Buy |
+105,000
| New | +$726K | 0.63% | 54 |
|
|
2016
Q2 | – | Sell |
-105,000
| Closed | -$463K | – | 97 |
|
|
2016
Q1 | $463K | Buy |
105,000
+45,000
| +75% | +$198K | 0.43% | 66 |
|
|
2015
Q4 | $349K | Sell |
60,000
-15,000
| -20% | -$87.3K | 0.33% | 81 |
|
|
2015
Q3 | $429K | Sell |
75,000
-2,500
| -3% | -$14.3K | 0.44% | 67 |
|
|
2015
Q2 | $578K | Sell |
77,500
-2,500
| -3% | -$18.6K | 0.48% | 59 |
|
|
2015
Q1 | $478K | Buy |
+80,000
| New | +$478K | 0.41% | 65 |
|